🇺🇸 FDA
Pipeline program

telbivudine (ROADMAP)

MOH-05

Approved small_molecule active

Quick answer

telbivudine (ROADMAP) for Hepatitis B, Chronic is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Hepatitis B, Chronic
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials